This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Krober, M. S. Articles by van Hamont, J. E. Search for Related Content PubMed PubMed Citation Articles by Krober, M. S. Articles by van Hamont, J. E. Social Bookmarking                   What's this?

Optimal Dosing Interval for Penicillin Treatment of Streptococcal Pharyngitis

Department of Pediatrics, madigan Army medical Center, Tacoma, WA 98431

Michael R. Weir, MD

Department of Pediatrics, madigan Army medical Center, Tacoma, WA 98431

Nicholas J. Themelis, MD

Department of Pediatrics, madigan Army medical Center, Tacoma, WA 98431

John E. van Hamont, Ph.D

Department of Clinical Investigation, Madigan Army Medical Center, Tacoma, WA 98431

One-hundred-forty-two children with symptomatic pharyngitis had throat cultures positive for group A beta-hemolytic streptococci (GABHA). All were treated orally with penicillin V for ten days. Patients were randomly assigned to receive daily doses of 250 mg four times daily, 500 mg twice daily, or 1000 mg once daily. They were followed four weeks for either recurrent symptomatic pharyngitis or asymptomatic repeat positive throat culture. Patients treated two or four times daily had comparable outcomes. Children given penicillin once daily were more likely to have persistent positive culture after 48 hours treatment (5 of 48 or 10.4% vs. none of 94, p=.004) and more likely to have recurrent positive cultures after end of treatment (10 of 43 or 23% vs. 8 of 94 or 8%, p=.04). The treatment regime of penicillin V 500 mg twice daily is recommended for treatment of pharyngitis due to GABHS.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. E. Pichichero The Importance of Bacteriologic Eradication in the Treatment of Group A Streptococcal Tonsillopharyngitis Clinical Pediatrics, May 1, 2007; 46(4_suppl): 3S - 16S. [Abstract] [PDF]

				C. Curtin-Wirt, J. R. Casey, P. C. Murray, C. T. Cleary, W. J. Hoeger, S. M. Marsocci, M. L. Murphy, A. B. Francis, and M. E. Pichichero Efficacy of Penicillin vs. Amoxicillin in Children with Group A Beta Hemolytic Streptococcal Tonsillopharyngitis Clinical Pediatrics, April 1, 2003; 42(3): 219 - 225. [Abstract] [PDF]